Introducing AOD-9604 during this natural lipolytic window amplifies the effect
If the solution turns cloudy, develops visible particles, changes color, or develops an unusual odor, it has degraded and should be discarded
Treat its essential partner, the diluent, with the same level of respect
3 RGN-259 Phase 3 Trial in Neurotrophic Keratopathy Sosne et al., International Journal of Molecular Sciences (2022) This Phase 3 randomized, placebo-controlled, double-masked clinical trial evaluated topical 0.1% RGN-259 (full-length recombinant T4 ophthalmic solution) in patients with neurotrophic keratopathy
Fleming Island Northeast Florida Between the Florida heat, active weekends on the river, and demanding schedules, Fleming Island and Clay County patients often come to us running on empty